DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/32zh63/pen_needles) has announced the addition of the "Pen Needles Market by Type, Needle Length, Therapy - Analysis & Global Forecast to 2019" report to their offering.
The global pen needles market is expected to reach $2,105 million in 2019 from $1,283 million in 2014, growing at a CAGR of 10.4%
The market is dominated by Europe, followed by North America, Asia, and Rest of the World (RoW). Asia is expected to reach leadership position in terms of the value by 2019.
The pen needles market is highly competitive with a large number of players, including both big and small players, operating in this market. Needles are used by patients to deliver insulin daily to their body. Rise in the global diabetic population and the increasing need for safety injections have resulted in technological advancements in this field.
The key factors that are expected to spur the growth of this market are the rising global diabetic population, favorable reimbursement scenario in North America and Europe, technological advancements, and awareness campaigns and conferences to improve diabetes care and adoption market. However, poor reimbursement structure in developing countries, rising incidents of needlestick injuries (NSIs), and threats involved in reuse of pen needles are hindering the market growth.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Pen Needles Market, By Type
8 Pen Needles Market, By Length
9 Pen Needles Market, By Therapy
10 Pen Needles Market, By Geography
11 Competitive Landscape
12 Company Profiles
- Allison Medical, Inc.
- Artsana S.P.A.
- B. Braun Melsungen
- Becton, Dickinson And Company
- Htl-Strefa S.A.
- Novo Nordisk A/S
- Owen Mumford, Ltd.
- Terumo Corporation
- Ultimed, Inc.
- Ypsomed Holding Ag
For more information visit http://www.researchandmarkets.com/research/32zh63/pen_needles